CD8A and neoplasm: Importantly, treatment of tumor cells with the inhibitor of ferroptosis Fer-1, significantly reversed the increased sensitivity to CD8+ T cell-mediated killing in both BRQ treated and DHODH knocked-out (KO) cells.